Ortin Laboratories Limited

Equities

ORTINLAB

INE749B01020

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:50 2024-05-06 am EDT 5-day change 1st Jan Change
18.8 INR -3.79% Intraday chart for Ortin Laboratories Limited -5.34% -18.33%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Ortin Laboratories Limited Announces Board Appointments CI
Ortin Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Ortin Laboratories Limited Appoints Divya Purswani as Company Secretary and Compliance Officer CI
Ortin Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Ortin Laboratories Limited Announces Executive Changes CI
Ortin Laboratories Limited Appointment of Harish Sharma as Company Secretary CI
Ortin Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Drugs Control Authority Cancels Ortin Laboratories' Manufacturing License MT
Drugs Control Administration, Government of Telangana Cancels Manufacturing License of Ortin Laboratories Limited CI
Ortin Laboratories Limited Announces Resignation of Nitesh Kumar Sharma as Company Secretary/Compliance Officer CI
Ortin Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Ortin Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Ortin Laboratories Limited Announces Resignation of J R K Panduranga Rao as Independent Director CI
Ortin Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Ortin Laboratories Limited Announces Cessation of Bh. Satyanarayana Raju and G. Venkata Ramana, Directors CI
Ortin Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Ortin Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Ortin Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Ortin Laboratories Limited Announces Demise of Mohan Krishna Murthy, Whole-Time Director CI
Ortin Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Ortin Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Ortin Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Ortin Laboratories Limited Appoints Mr. S. Srinivas Kumar as CFO CI
Ortin Laboratories Limited Announces Management Changes CI
Ortin Laboratories Limited Appoints Pottur Sujatha as Additional Director CI
Chart Ortin Laboratories Limited
More charts
Ortin Laboratories Limited is engaged in manufacturing and trading of pharmaceuticals, drugs, and intermediates. It manufactures a range of pharmaceutical formulations of tablets, capsules, syrups, and dry powders. The Company's products include Acefinac, ACEFINAC-CZ, ACEFINAC-P, ACEFINAC-SP, ACTAZID, ACTY-P, ALERFEX-120, ALERFEX-180, ALERGID, ALERGID- L, AMLOBID, CARBAMOL, CARISNIL, CALDY-C AZITIN-500, DOCEF-200, GLYCITROL, GLYCITROL-M, LORACT, MEBOL, NEUROCOB, FERUP, IRFER Z, MINVITA-B, NILCID, ORICILLIN-DX, PEG POWDER, PEG-D POWDER, ALKASIT, COF-XL, DECODIL, ENCENIL and OROMOX DRY SYRUP. Its formulations include Anti Diabetics, Anti Allergics, Anti Anginal and Cardiovascular, Analgesics and Antipyretics, and Anti Biotics-Quinolones. Its active pharmaceutical ingredient (API) intermediates include Anti retro viral, Grignard, Diborane, Ciprofloxacin and Tramadol. It is also manufacturing for different importers to market their products in Russia, Ukraine, Kajakistan and South America.
More about the company
  1. Stock Market
  2. Equities
  3. ORTINLAB Stock
  4. News Ortin Laboratories Limited
  5. Drugs Control Authority Cancels Ortin Laboratories' Manufacturing License
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW